- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary Preventions in Belgium
Total 75 results
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
AstraZenecaTerminatedStroke Prevention in Patients With Atrial FibrillationSweden, Norway, Poland, United Kingdom, Finland, Denmark, United States, Czech Republic, Belgium
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus Infection PreventionGermany, Spain, Belgium, Sweden, United States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...European Society of AnaesthesiologyTerminatedChronic Pain | Phantom Limb Pain | PreventionUnited States, Austria, Belgium, Netherlands, Spain
-
Janssen Vaccines & Prevention B.V.Completed
-
Swedish Orphan BiovitrumTerminatedPrevention of Growth RestrictionBelgium, France, Germany, Hungary, Italy, Poland, Spain, Sweden, Czech Republic, Russian Federation
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Janssen Research & Development, LLCActive, not recruitingExtraintestinal Pathogenic Escherichia Coli PreventionUnited States, France, Belgium, Spain, Netherlands
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
BayerCompletedVenous Thromboembolism | PreventionBelgium, Italy, Poland, Spain, China, France, Denmark, Netherlands, Austria, Germany, Mexico, South Africa, Sweden, Colombia, Israel, Canada, Norway, Peru, Czech Republic
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
Janssen Research & Development, LLCActive, not recruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, Poland, Belgium, Canada
-
BayerJanssen Research & Development, LLC; Population Health Research InstituteCompletedPrevention & ControlBelgium, Finland, France, China, United States, Colombia, Ireland, Philippines, Japan, Hungary, Canada, Germany, Australia, Chile, Czechia, Korea, Republic of, Malaysia, Brazil, Denmark, Israel, Russian Federation, South Africa, Ecu... and more
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Swedish Orphan BiovitrumRecruitingSystemic Lupus Erythematosus | Macrophage Activation Syndrome | Still Disease | Secondary Hemophagocytic Lymphohistiocytosis | SJIA | AOSD | MASUnited States, Belgium, Italy, Netherlands, United Kingdom, China, France, Spain, Czechia, Canada, Sweden, Japan, Germany, Poland
-
Novartis PharmaceuticalsRecruitingPrimary Prevention of Atherosclerotic Cardiovascular DiseaseUnited States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
-
BayerTerminatedAtrial Fibrillation | Prevention of Stroke or Systemic EmbolismCanada, United States, Israel, Korea, Republic of, China, Taiwan, Belgium, Australia, Singapore, Malaysia, Slovakia, United Kingdom, Czechia, Latvia, Japan, Brazil, Lithuania, Germany, France, Sweden, Turkey, Switzerland, Estonia, Bul... and more
-
Galectin Therapeutics Inc.Active, not recruitingCirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal VaricesUnited States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
BayerCompletedHemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic EventsSpain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal